Fundz

Secura Bio, Inc. Appoints Charles (Chip) R. Romp as Chief Executive Officer, Succeeding Joseph (Joe) M. Limber

PRIVATEOct 15, 2024

Position

Chief Executive Officer

Company

Secura Bio

Charles R. Romp
cromp@securabio.com
Las VegasBiotechnologyHealth CareTherapeuticsPharmaceutical

Description

Secura Bio, Inc announced the appointment of Charles (Chip) R Romp as its Chief Executive Officer, succeeding Joseph (Joe) M Limber. Chip Romp brings over 25 years of experience in the pharmaceutical industry, with an emphasis on leading commercial organizations in the oncology and hematology space. The company looks forward to benefiting from his experience as they continue to realize their potential.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Secura Bio, and when

A new leader at Secura Bio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Secura Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Secura Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Secura Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Secura Bio

Location

Las Vegas, Nevada, United States

About

Secura Bio is an integrated, commercial-stage pharmaceutical company dedicated to the worldwide commercialization of significant oncology therapies for physicians and their patients. Its product, COPIKTRA®, is currently approved for the treatment of multiple B-cell malignancies and is also being developed for the treatment of peripheral T-cell lymphoma, for which it has received Fast Track status in the United States and is being investigated in combination with other agents through investigator-sponsored studies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Secura Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Charles
Likely contact at this company
••••••••@••••••••

See Charles's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Secura Bio's next move

Learn about Strategic plan

Secura Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.